Literature DB >> 10393085

Expression of I2PP2A, an inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity.

S W Al-Murrani1, J R Woodgett, Z Damuni.   

Abstract

Transient expression of I2PP2A, a potent inhibitor of protein phosphatase 2A (PP2A), in HEK-293 cells increased the concentration and DNA binding of the proto-oncogene c-Jun. In contrast, expression of the catalytic subunit of PP2A (PP2AC) markedly decreased the concentration and DNA binding of c-Jun. Expression of I2PP2A also increased the transcriptional activity of activator protein-1, and this effect was diminished in a dose-dependent manner by expression of PP2AC. Densitometric analysis following Western blotting of extracts with antibodies specific for phospho-Ser63 and Ser73 suggests that the effects of I2PP2A and PP2AC expression might be mediated, in part, by changes in the phosphorylation of c-Jun at Ser63. The results indicate that I2PP2A elicits effects that are consistent with it acting as an inhibitor of PP2A in intact cells, and suggest that PP2A might exhibit site selectivity with respect to c-Jun phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393085      PMCID: PMC1220359     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.

Authors:  B Binétruy; T Smeal; M Karin
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

2.  Identification and preliminary characterization of two related proliferation-associated nuclear phosphoproteins.

Authors:  S N Malek; A I Katumuluwa; G R Pasternack
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

3.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.

Authors:  P Angel; I Baumann; B Stein; H Delius; H J Rahmsdorf; P Herrlich
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

4.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Biochemical characterization of mapmodulin, a protein that binds microtubule-associated proteins.

Authors:  N Ulitzur; C Rancaño; S R Pfeffer
Journal:  J Biol Chem       Date:  1997-11-28       Impact factor: 5.157

Review 7.  Okadaic acid: a new probe for the study of cellular regulation.

Authors:  P Cohen; C F Holmes; Y Tsukitani
Journal:  Trends Biochem Sci       Date:  1990-03       Impact factor: 13.807

Review 8.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

9.  Protein phosphatase 2A reverses phosphorylation of c-Jun specified by the delta domain in vitro: correlation with oncogenic activation and deregulated transactivation activity of v-Jun.

Authors:  E J Black; A J Street; D A Gillespie
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

10.  Phosphorylation of c-jun mediated by MAP kinases.

Authors:  B J Pulverer; J M Kyriakis; J Avruch; E Nikolakaki; J R Woodgett
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

View more
  24 in total

Review 1.  Protein phosphatase 2A: a target for anticancer therapy.

Authors:  Danilo Perrotti; Paolo Neviani
Journal:  Lancet Oncol       Date:  2013-05       Impact factor: 41.316

2.  Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma.

Authors:  Kerstin Krause; Susanne Prawitt; Markus Eszlinger; Christian Ihling; Andrea Sinz; Katrin Schierle; Oliver Gimm; Henning Dralle; Frank Steinert; Sien-Yi Sheu; Kurt W Schmid; Dagmar Fuhrer
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

3.  Active-site mutations impairing the catalytic function of the catalytic subunit of human protein phosphatase 2A permit baculovirus-mediated overexpression in insect cells.

Authors:  T Myles; K Schmidt; D R Evans; P Cron; B A Hemmings
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

4.  Potential contribution of SET and c-MYC deregulation to promote extracellular matrix remodelling in hepatocellular carcinoma.

Authors:  Ion Cristóbal; Blanca Torrejón; Federico Rojo; Jesús García-Foncillas
Journal:  Br J Pharmacol       Date:  2018-01-05       Impact factor: 8.739

5.  Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia.

Authors:  Ion Cristóbal; Laura Garcia-Orti; Cristina Cirauqui; Xabier Cortes-Lavaud; María A García-Sánchez; María J Calasanz; María D Odero
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

6.  Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential.

Authors:  M-H Hung; Y-L Chen; P-Y Chu; C-T Shih; H-C Yu; W-T Tai; C-W Shiau; K-F Chen
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

7.  Protein phosphatase 2A regulates innate immune and proteolytic responses to cigarette smoke exposure in the lung.

Authors:  Alison M Wallace; Andrew Hardigan; Patrick Geraghty; Shaneeza Salim; Adam Gaffney; Jincy Thankachen; Leo Arellanos; Jeanine M D'Armiento; Robert F Foronjy
Journal:  Toxicol Sci       Date:  2012-01-05       Impact factor: 4.849

8.  Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.

Authors:  Hugh K Arnold; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 9.  Anp32e (Cpd1) and related protein phosphatase 2 inhibitors.

Authors:  Tomás A Santa-Coloma
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

10.  X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis.

Authors:  Zipeng Cao; Ruowen Zhang; Jingxia Li; Haishan Huang; Dongyun Zhang; Jingjie Zhang; Jimin Gao; Jingyuan Chen; Chuanshu Huang
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.